FDA
-
-
-
-
-
-
-
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Delcath Systems presents liver cancer treatment data at breast cancer congress
-
-
-
-
-
-
-
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology
-
-
-
-
-
-
-
Delcath Systems publishes subgroup analysis of cancer treatment study
-
-
-
-
-
-
-
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Delcath Systems reports CHOPIN trial meets primary endpoint
-
-
-
-
-
-
-
Delcath Systems doses first patient in liver cancer drug trial
-
334,854 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


